ANI Pharmaceuticals reported $51.84M in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
AbbVie USD 6.88B 156M Sep/2026
ANI Pharmaceuticals USD 51.84M 12M Sep/2026
Aurora Cannabis CAD -3.17M 10.29M Jun/2026
Canopy Growth CAD -2.03M 143.62M Jun/2026
Eli Lilly USD 13.09B 635M Sep/2026
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Novartis USD 1.78B 2.4B Sep/2026
Omeros USD -48.15M 7.25M Sep/2023
Perrigo USD 27.2M 116.6M Sep/2026
Sun Pharmaceuticals INR 39.07B 3.5B Sep/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026